<DOC>
	<DOCNO>NCT02994381</DOCNO>
	<brief_summary>This open-label , non-randomized , single oral dose study healthy male subject . All subject receive single oral dose 10 mL [ 14C ] -RPC1063 Solution ( 0.1 mg/mL ) , contain NMT 1.3 MBq ( 37 μCi ) 14C .</brief_summary>
	<brief_title>A Single Dose Oral Excretion Balance Study 14C-RPC1063 Healthy Male Adults</brief_title>
	<detailed_description>Subjects screen eligibility participate study 28 day dose . Subjects admit clinical unit morning Day -1 prior IMP administration . Subjects dose morning Day 1 follow standard breakfast , remain resident clinic 168 h dosing . It plan subject release group subject achieve mass balance cumulative recovery &gt; 90 % &lt; 1 % dose administer collected urine faeces within 2 separate , consecutive 24 h period . This may earlier 168 h post-dose sooner 96 h post-dose . In case , collection sample ( blood , urine faeces ) stop subject undergo discharge assessment . If criterion meet subject Day 8 , home collection urine faeces may request discretion investigator individual subject . A follow-up phone call take place 5 10 day discharge .</detailed_description>
	<criteria>1 . Subject male 2 . Subject 30 65 year age 3 . Subject body weight least 50 kg ; body mass index ( BMI ) 18.0 32.0 kg/m2 , outside range , consider clinically significant investigator 4 . Subject willing able communicate participate whole study 5 . Subject regular bowel movement ( average stool production ≥1 ≤3 stool per day ) 6 . Subject suitable vein multiple cannulation assess investigator screen 7 . Subject able comprehend inform consent form , provide write informed consent , able comply requirement study . 8 . Subject agree use adequate method contraception 1 . Subject receive investigational medicinal product ( IMP ) clinical research study within previous 3 month 2 . Subject study site employee immediate family member study site sponsor employee 3 . Subject history drug alcohol abuse past 2 year 4 . Subject regular alcohol consumption &gt; 21 unit per week ( 1 unit = ½ pint beer , 25 mL 40 % spirit 125 mL glass wine ) 5 . Subject current smoker smoke within last 12 month ; include cigarette , ecigarettes nicotine replacement product . Positive cotinine test result screen admission 6 . Subject radiation exposure , include present study , exclude background radiation include diagnostic xrays medical exposure , exceed 5 millisievert ( mSv ) last 12 month 10 mSv last 5 year . No occupationally expose worker , define Ionising Radiation Regulations 1999 , shall participate study 7 . Subjects enrol absorption , distribution , metabolism elimination ( ADME ) study last 12 month 8 . Subject clinically significant abnormal biochemistry haematology judge investigator 9 . Subject positive drug abuse test result 10 . Subject positive hepatitis B surface antigen ( HBsAg ) , hepatitis C virus antibody ( HCV Ab ) human immunodeficiency virus ( HIV ) result 11 . Subject evidence renal impairment screen admission , indicate estimate creatinine clearance ( CLcr ) &lt; 90 mL/min use CockcroftGault equation 12 . Subject alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) concentration &gt; 1.25 × ULN screen 13 . Subject history cardiovascular , renal , hepatic , chronic respiratory gastrointestinal disease judge investigator 14 . Subject serious adverse reaction serious hypersensitivity drug formulation excipients 15 . Subject presence history clinically significant allergy require treatment , judge investigator . Hayfever allow unless active 16 . Subject donate lose great 400 mL blood within previous 3 month 17 . Subject taking , take , prescribed overthecounter drug ( 2 g per 24 h paracetamol ) dietary herbal remedy within 14 day IMP administration , take St. John 's wort within 28 day IMP administration . Exceptions may apply case case basis , consider interfere objective study , agree PI sponsor 's medical monitor . 18 . Subject fail satisfy investigator fitness participate reason</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Healthy Male Adults</keyword>
	<keyword>14C</keyword>
	<keyword>RPC1063</keyword>
</DOC>